SFBC International Announces Upcoming Conference Call to Discuss First

    Business Editors/Health/Medical Writers

    MIAMI--(BUSINESS WIRE)--April 15, 2005--SFBC International, Inc. (NASDAQ:SFCC), a provider of drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies, will report its financial results for the first quarter 2005 and will host a live conference call and listen-only Webcast to discuss these results at 10:00 a.m. Eastern Time on Thursday, April 28, 2005. In addition, a press release announcing the company's financial results will be released before the market opens on Thursday, April 28, 2005. SFBC's financial results for the first quarter of 2005 will include PharmaNet's results for the first time.
    Lisa Krinsky, Chairman and President; Arnold Hantman, Chief Executive Officer; David Natan, Chief Financial Officer; Jeffrey McMullen, President and Chief Executive Officer of PharmaNet; and John P. Hamill, Chief Financial Officer of PharmaNet, will host the call and will also be available to answer questions. Mr. McMullen and Mr. Hamill will also be available to answer questions about the integration of PharmaNet into SFBC.
    To participate, please dial the following teleconference number five minutes prior to the scheduled conference time:

Date: Thursday, April 28, 2005

Time: 10:00 a.m. Eastern Time 9:00 a.m. Central Time 8:00 a.m. Mountain Time 7:00 a.m. Pacific Time

Dial-In Number: 800-473-6123 (Domestic) 973-582-2706 (International)

    A listen-only Webcast of the conference call will be available at http://www.sfbci.com.
    For those unable to participate in the live conference, there will be an audio replay available from April 28, 2005 at approximately 12:30 p.m. Eastern Time through May 12, 2005 at 11:59 p.m. Eastern Time.

To listen to the audio replay, please dial: Domestic: 877-519-4471 International: 973-341-3080 Replay Pin code: 5958655

    A replay of the live Webcast will also be available at http://www.sfbci.com from April 28, 2005 at approximately 12:30 p.m. Eastern Time through May 28, 2005 at 11:59 p.m. Eastern Time.

    About SFBC International, Inc.

    SFBC International, Inc. provides early and late stage clinical drug development services to branded pharmaceutical, biotechnology, generic drug and medical device companies around the world. SFBC has more than 30 offices located in North America, Europe, South America, India, and Australia. In early clinical development services, SFBC specializes primarily in the areas of Phase I and early Phase II clinical trials and bioanalytical laboratory services, including early clinical pharmacology. SFBC also provides late stage clinical development services globally that focus on Phase II through IV clinical trials. SFBC also offers a range of complementary services, including data management and biostatistics, clinical laboratory services, medical and scientific affairs, regulatory affairs and submissions, and clinical IT solutions. Additional information is available on SFBC's website at http://www.sfbci.com.

--30--GAA/mi*

CONTACT: SFBC International, Inc., Miami Ana Lopez, 305-895-0304 or Financial Dynamics Evan Smith, CFA / Erica Pettit 212-850-5606 / 212-850-5614

KEYWORD: FLORIDA INDUSTRY KEYWORD: MEDICAL DEVICES PHARMACEUTICAL MEDICAL BIOTECHNOLOGY EARNINGS CONFERENCE CALLS SOURCE: SFBC International, Inc.

Copyright Business Wire 2005